Interaction of Clostridium Perfringens Theta-haemolysin, a Contaminant of Commercial Phospholipase C, with Erythrocyte Ghost Membranes and Lipid Dispersions. A Morphological Study
Overview
Biophysics
Authors
Affiliations
Commercially available preparations of phospholipase C from Clostridium perfringens are commonly contaminated with theta haemolysin, one of a group of bacterial haemolysins called oxygen labile (O-labile) haemolysins. Treatment of erythrocyte ghosts and a mixed lipid dispersion containing cholesterol with commercially available phospholipase C in the absence of Ca-2+ and the presence of phosphate buffer and/or EDTA resulted in the formation and release of ring or arc-shaped structures. Highly purified phospholipase C, free of theta-haemolysin, produced no changes in the morphology of erythrocyte ghosts or lipid dispersions in the presence of phosphate or EDTA, but caused the formation of typical diglyceride droplets in the presence of Ca-2+ in the absence of these inhibitors. Ring structures, identical to those caused by commercial phospholipase C, were formed on addition of highly purified theta-haemolysin to erythrocyte ghost membranes, lipid dispersions containing cholesterol and cholesterol dispersions, but not on treatment of membranes from Micrococcus lysodeikticus. Heat-inactivated O-haemolysin (60 degrees C for 10 min) produced no such effects. The dimensions of rings and arcs displayed heterogeneity. The outside diameters in various preparations varied from approx. 27-58 nm with border thickness of 4.1-7.8 nm.
Sakurai J, Ochi S, Tanaka H Infect Immun. 1993; 61(9):3711-8.
PMID: 8395469 PMC: 281068. DOI: 10.1128/iai.61.9.3711-3718.1993.
Honeyman T, Strohsnitter W, Scheid C, Schimmel R Biochem J. 1983; 212(2):489-98.
PMID: 6411068 PMC: 1152072. DOI: 10.1042/bj2120489.
Thelestam M, Mollby R Infect Immun. 1980; 29(3):863-72.
PMID: 6253400 PMC: 551210. DOI: 10.1128/iai.29.3.863-872.1980.
Mechanism of membrane damage by streptolysin-O.
Bhakdi S, Tranum-Jensen J, Sziegoleit A Infect Immun. 1985; 47(1):52-60.
PMID: 3880730 PMC: 261464. DOI: 10.1128/iai.47.1.52-60.1985.
Hugo F, Reichwein J, Arvand M, Kramer S, Bhakdi S Infect Immun. 1986; 54(3):641-5.
PMID: 3781620 PMC: 260217. DOI: 10.1128/iai.54.3.641-645.1986.